These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10385060)

  • 1. Effects of ammonia solution on the gastric mucosa in cirrhotic rats and therapeutic effects of geranylgeranylacetone.
    Sugimoto M; Machida Y; Ito K
    J Gastroenterol Hepatol; 1999 Jun; 14(6):529-33. PubMed ID: 10385060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effects of geranylgeranylacetone on rat ethanol-induced gastritis.
    Ning JW; Lin GB; Ji F; Xu J; Sharify N
    World J Gastroenterol; 2012 May; 18(18):2262-9. PubMed ID: 22611321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acidified aspirin-induced gastric lesion in rats with hepatic cirrhosis produced by N-nitrosodiethylamine or carbon tetrachloride. Effect of aldioxa on gastric lesions].
    Uchida M; Hamura H; Takagi S; Noguchi Y; Shibata H; Honda H
    Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):111-20. PubMed ID: 8144103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal lesions of the stomach in liver cirrhosis with a special reference to phospholipid metabolism.
    Hosokawa Y
    Gastroenterol Jpn; 1991 Jun; 26(3):329-35. PubMed ID: 1889690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geranylgeranylacetone protects the human gastric mucosa from diclofenac-induced injury via induction of heat shock protein 70.
    Yanaka A; Zhang S; Sato D; Tauchi M; Suzuki H; Shibahara T; Matsui H; Nakahara A; Hyodo I
    Digestion; 2007; 75(2-3):148-55. PubMed ID: 17684364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the antiulcer drug geranylgeranylacetone on aspirin-induced gastric ulcers in rats.
    Murakami M; Oketani K; Fujisaki H; Wakabayashi T; Ohgo T; Okabe S
    Jpn J Pharmacol; 1982 Apr; 32(2):299-306. PubMed ID: 7098146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric mucosal protection via enhancement of MUC5AC and MUC6 by geranylgeranylacetone.
    Nam SY; Kim N; Lee CS; Choi KD; Lee HS; Jung HC; Song IS
    Dig Dis Sci; 2005 Nov; 50(11):2110-20. PubMed ID: 16240224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a 72-kDa heat shock protein, and its cytoprotective function, in gastric mucosa in cirrhotic rats.
    Watanabe D; Otaka M; Mikami K; Yoneyama K; Goto T; Miura K; Ohshima S; Lin JG; Shibuya T; Segawa D; Kataoka E; Konishi N; Odashima M; Sugawara M; Watanabe S
    J Gastroenterol; 2004 Aug; 39(8):724-33. PubMed ID: 15338365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa.
    Hirakawa T; Rokutan K; Nikawa T; Kishi K
    Gastroenterology; 1996 Aug; 111(2):345-57. PubMed ID: 8690199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of teprenone on portal hypertensive gastric mucosa.
    Tanoue K; Tarnawski AS; Kishihara F; Ohta M; Hashizume M; Sugimachi K; Sarfeh IJ
    Digestion; 1996; 57(1):35-40. PubMed ID: 8626046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric damage and body weight loss in LHA-lesioned rats: effects of cytoprotective geranylgeranylacetone.
    Namiki T; Egawa M; Inoue S; Tominaga S; Takamura Y
    Am J Physiol; 1994 Feb; 266(2 Pt 2):R503-9. PubMed ID: 8141409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geranylgeranylacetone, a gastromucoprotective drug, protects against NSAID-induced esophageal, gastroduodenal and small intestinal mucosal injury in healthy subjects: A prospective randomized study involving a comparison with famotidine.
    Umegaki E; Kuramoto T; Kojima Y; Nouda S; Ishida K; Takeuchi T; Inoue T; Tokioka S; Higuchi K
    Intern Med; 2014; 53(4):283-90. PubMed ID: 24531083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a gastric mucosal protecting agent in rats with liver cirrhosis.
    Kurihara T; Akimoto M; Kurokawa K; Ishiguro H; Niimi A; Maeda A; Shigemoto M; Yamashita K; Yokoyama I
    J Gastroenterol Hepatol; 1992; 7(4):405-10. PubMed ID: 1515567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.
    Morimoto Y; Shimohara K; Oshima S; Sukamoto T
    Jpn J Pharmacol; 1991 Dec; 57(4):495-505. PubMed ID: 1803065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geranylgeranylacetone, an anti-ulcer drug, stimulates hexosamine production in a rat gastric mucosal cell line through binding to a specific cytosolic protein.
    Hassan S; Kinoshita Y; Okada A; Maekawa T; Fukui H; Chiba T
    J Gastroenterol Hepatol; 1998 Aug; 13(8):809-15. PubMed ID: 9736174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective and preventive effects of teprenone on gastric mucosal lesions in rats.
    Nishida K; Ohta Y; Ishiguro I
    Eur J Pharmacol; 1998 Jul; 354(1):51-8. PubMed ID: 9726630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventive effects of troxipide on a newly developed model of acute gastric mucosal lesion (AGML) induced by ischemia/reperfusion plus ammonia in the rat].
    Momo K; Hoshina K; Ishibashi Y; Saito T
    Nihon Yakurigaku Zasshi; 1994 Oct; 104(4):313-23. PubMed ID: 7959422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of geranylgeranylacetone on aspirin-induced changes in gastric glycoproteins.
    Oketani K; Murakami M; Fujisaki H; Wakabayashi T; Hotta K
    Jpn J Pharmacol; 1983 Jun; 33(3):593-601. PubMed ID: 6620729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against alcohol-induced gastric mucosal injury by geranylgeranylacetone: effect of indomethacin.
    Bilski J; Murty VL; Nadziejko C; Sarosiek J; Aono M; Moriga M; Slomiany A; Slomiany BL
    Digestion; 1988; 41(1):22-33. PubMed ID: 3203824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone.
    Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
    Biol Pharm Bull; 2005 Aug; 28(8):1424-30. PubMed ID: 16079487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.